Zurcher Kantonalbank Zurich Cantonalbank Purchases 2,817 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)

Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 23.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,072 shares of the company’s stock after buying an additional 2,817 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Health Catalyst were worth $140,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Stratos Wealth Partners LTD. acquired a new stake in shares of Health Catalyst during the 3rd quarter worth approximately $114,000. MQS Management LLC acquired a new stake in shares of Health Catalyst in the 3rd quarter valued at $116,000. Versor Investments LP bought a new position in shares of Health Catalyst in the 3rd quarter valued at $117,000. Fox Run Management L.L.C. acquired a new position in shares of Health Catalyst during the 3rd quarter worth $166,000. Finally, Mackenzie Financial Corp acquired a new position in shares of Health Catalyst during the 4th quarter worth $172,000. 85.00% of the stock is owned by institutional investors.

Health Catalyst Price Performance

Shares of HCAT opened at $6.65 on Thursday. The business has a 50-day moving average of $7.08 and a 200-day moving average of $8.16. The company has a debt-to-equity ratio of 0.62, a current ratio of 4.42 and a quick ratio of 4.42. The company has a market capitalization of $392.55 million, a price-to-earnings ratio of -3.17 and a beta of 1.32. Health Catalyst, Inc. has a 1 year low of $5.45 and a 1 year high of $14.37.

Health Catalyst (NASDAQ:HCAT) last released its earnings results on Thursday, February 22nd. The company reported ($0.21) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.06. The business had revenue of $75.08 million during the quarter, compared to the consensus estimate of $73.67 million. Health Catalyst had a negative net margin of 39.92% and a negative return on equity of 12.19%. As a group, equities research analysts anticipate that Health Catalyst, Inc. will post -0.47 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on HCAT shares. Canaccord Genuity Group decreased their target price on Health Catalyst from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Friday, February 23rd. Guggenheim raised shares of Health Catalyst from a “neutral” rating to a “buy” rating and set a $14.00 price target on the stock in a report on Friday, January 26th. Evercore ISI dropped their price objective on shares of Health Catalyst from $11.00 to $10.00 and set an “outperform” rating for the company in a research note on Friday, February 23rd. KeyCorp reaffirmed a “sector weight” rating on shares of Health Catalyst in a research note on Wednesday, April 10th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $16.00 price target on shares of Health Catalyst in a research note on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $12.10.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.